Perceptions of parents of pediatric patients with acute lymphoblastic leukemia on oral chemotherapy administration: A qualitative analysis

被引:11
|
作者
Tang, Natalie [1 ]
Kovacevic, Anja [2 ]
Zupanec, Sue [3 ]
Sivananthan, Araby [4 ]
Patel, Rikesh [1 ,4 ]
Patel, Priya [1 ,4 ]
Vennettilli, Ashlee [4 ]
Paw Cho Sing, Edric [1 ,4 ]
Alexander, Sarah [5 ]
Sung, Lillian [4 ,5 ]
Dupuis, L. Lee [1 ,2 ,4 ]
机构
[1] Univ Toronto, Leslie Dan Fac Pharm, Toronto, ON, Canada
[2] Hosp Sick Children, Dept Pharm, Toronto, ON, Canada
[3] Hosp Sick Children, Dept Nursing, Toronto, ON, Canada
[4] Hosp Sick Children, Res Inst, Toronto, ON, Canada
[5] Hosp Sick Children, Div Haematol Oncol, Toronto, ON, Canada
关键词
adherence; chemotherapy; qualitative research; MEDICATION ADHERENCE; CHILDREN; BARRIERS; RELAPSE; RISK; MERCAPTOPURINE; ADOLESCENTS; STRATEGIES; MEDICINE;
D O I
10.1002/pbc.29329
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective To describe the experiences and perspectives of parents of pediatric patients with acute lymphoblastic leukemia (ALL) regarding oral chemotherapy administration during maintenance therapy. Methods English-speaking parents of patients 4 to <18 years who were receiving ALL maintenance oral chemotherapy were eligible to participate in this mixed methods study. Using semi-structured interviews, we asked participants how difficult they found oral chemotherapy administration. We also probed regarding barriers and facilitators of oral chemotherapy administration and strategies used to overcome challenges. Lastly, we asked participants for their advice to future parents giving oral chemotherapy to their children. Results Twenty-three participants were interviewed. One-fifth of participants stated that oral chemotherapy administration at home was hard or very hard. Common factors influencing oral chemotherapy administration were product-related (e.g., formulation) and treatment-related adverse effects (e.g., nausea), lifestyle adjustment (e.g., fitting in with family schedule), and attitudes (e.g., onus of medication administration). Strategies to address oral chemotherapy administration included several administration techniques, scheduling of medication administration, and normalization of medication taking. Conclusions Oral chemotherapy administration during ALL maintenance therapy was hard for some parents. Identification of these parents and discussion of strategies to facilitate adherence to oral chemotherapy regimens may optimize patient outcomes.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Oral Manifestations in Pediatric Patients Receiving Chemotherapy for Acute Lymphoblastic Leukemia.
    Ponce-Torres, Elena
    del Socorro Ruiz-Rodriguez, Ma.
    Alejo-Gonzalez, Francisco
    Hernandez-Sierra, Juan Francisco
    Pozos-Guillen, Amaury de J.
    JOURNAL OF CLINICAL PEDIATRIC DENTISTRY, 2010, 34 (03) : 275 - 279
  • [2] Intravenous and Intramuscular Administration of Asparaginase in Pediatric Patients with Acute Lymphoblastic Leukemia: Treatment Patterns and Perceptions
    Bernard, Celine
    Hall, Megan P.
    Doede, Tina
    BLOOD, 2015, 126 (23)
  • [3] Caregiver Survey Results Related to Handling of Oral Chemotherapy for Pediatric Patients With Acute Lymphoblastic Leukemia
    Held, Kristin
    Ryan, Robin
    Champion, Judy M.
    August, Keith
    Radhi, Mohamed A.
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2013, 35 (06) : E249 - E253
  • [4] Psychological Impact of Chemotherapy for Childhood Acute Lymphoblastic Leukemia on Patients and Their Parents
    Sherief, Laila M.
    Kamal, Naglaa M.
    Abdalrahman, Hadel M.
    Youssef, Doaa M.
    Alhady, Mohamed A. Abd
    Ali, Adel S. A.
    Elbasset, Maha Aly Abd
    Hashim, Hiatham M.
    MEDICINE, 2015, 94 (51)
  • [5] Parents' Experiences with Home-Based Oral Chemotherapy Prescribed to a Child Diagnosed with Acute Lymphoblastic Leukemia: A Qualitative Study
    Camire-Bernier, Etienne
    Nidelet, Erwan
    Baghdadli, Amel
    Demers, Gabriel
    Boulanger, Marie-Christine
    Brisson, Marie-Claude
    Michon, Bruno
    Lauzier, Sophie
    Laverdiere, Isabelle
    CURRENT ONCOLOGY, 2021, 28 (06) : 4377 - 4391
  • [6] Oral Mucositis in Pediatric Patients in Treatment for Acute Lymphoblastic Leukemia
    Arrais Ribeiro, Isabella Lima
    Tolentino Limeira, Rebecca Rhuanny
    de Castro, Ricardo Dias
    Ferreti Bonan, Paulo Rogerio
    Gondim Valenca, Ana Maria
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2017, 14 (12)
  • [7] Dietary intakes in pediatric patients with acute lymphoblastic leukemia during chemotherapy
    Chatvuttinun, Suthida
    Phoonlapdacha, Phanphen
    Suthutvoravut, Umaporn
    Chongviriyaphan, Nalinee
    FASEB JOURNAL, 2010, 24
  • [8] METABOLIC RISK IN PEDIATRIC PATIENTS AFTER CHEMOTHERAPY FOR ACUTE LYMPHOBLASTIC LEUKEMIA
    Cecinati, V
    Del Vecchio, M.
    Santoro, N.
    Santoro, C.
    Perillo, T.
    Dell'Acqua, A.
    Faienza, M. F.
    Cavallo, L.
    De Mattia, D.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 (07): : S60 - S60
  • [9] Rituximab administration in pediatric patients with newly diagnosed acute lymphoblastic leukemia
    Keito Hoshitsuki
    Yinmei Zhou
    April M. Miller
    John K. Choi
    Hope D. Swanson
    Nickhill H. Bhakta
    Sima Jeha
    Seth E. Karol
    Raul C. Ribeiro
    Jeffrey E. Rubnitz
    Charles G. Mullighan
    Cheng Cheng
    Jun J. Yang
    Mary V. Relling
    Ching-Hon Pui
    Hiroto Inaba
    Leukemia, 2023, 37 : 1782 - 1791
  • [10] Rituximab administration in pediatric patients with newly diagnosed acute lymphoblastic leukemia
    Hoshitsuki, Keito
    Zhou, Yinmei
    Miller, April M.
    Choi, John K.
    Swanson, Hope D.
    Bhakta, Nickhill H.
    Jeha, Sima
    Karol, Seth E.
    Ribeiro, Raul C.
    Rubnitz, Jeffrey E.
    Mullighan, Charles G.
    Cheng, Cheng
    Yang, Jun J.
    Relling, Mary V.
    Pui, Ching-Hon
    Inaba, Hiroto
    LEUKEMIA, 2023, 37 (9) : 1782 - 1791